Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.
作者信息
Denson Lee A, Long Millie D, McGovern Dermot P B, Kugathasan Subra, Wu Gary D, Young Vincent B, Pizarro Theresa T, de Zoeten Edwin F, Stappenbeck Thaddeus S, Plevy Scott E, Abraham Clara, Nusrat Asma, Jobin Christian, McCole Declan F, Siegel Corey A, Higgins Peter D R, Herfarth Hans H, Hyams Jeffrey, Sandborn William J, Loftus Edward V, Kappelman Michael D, Lewis James D, Parkos Charles A, Sartor R Balfour
机构信息
Division of Pediatric Gastroenterology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH, USA.
出版信息
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):677-82. doi: 10.1097/MIB.0b013e31828134b3.
Abstract
摘要
相似文献
1
Challenges in IBD research: update on progress and prioritization of the CCFA's research agenda.
Inflamm Bowel Dis. 2013 Mar-Apr;19(4):677-82. doi: 10.1097/MIB.0b013e31828134b3.
2
Challenges in IBD research: Assessing progress and rethinking the research agenda.
Inflamm Bowel Dis. 2008 May;14(5):687-708. doi: 10.1002/ibd.20371.
3
IBD legislation introduced.
Gastroenterology. 2007 Apr;132(4):1215. doi: 10.1053/j.gastro.2007.03.022.
4
Challenges in IBD Research: updating the scientific agendas.
Inflamm Bowel Dis. 2003 May;9(3):137-53. doi: 10.1097/00054725-200305000-00001.
5
Crohn's & Colitis Foundation Engaging IBD Patients for 50 Years.
Inflamm Bowel Dis. 2018 Apr 23;24(5):930-931. doi: 10.1093/ibd/izy071.
6
Inflammatory bowel disease in the 21(st) century in China: turning challenges into opportunities.
J Dig Dis. 2012 Apr;13(4):195-9. doi: 10.1111/j.1751-2980.2012.00579.x.
7
Inflammatory bowel disease: diagnosis and research trends: the clinical lab is playing an increasingly important role.
MLO Med Lab Obs. 2012 Aug;44(8):8, 10, 12; quiz 14.
8
Challenges in IBD Research: Pragmatic Clinical Research.
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S40-S47. doi: 10.1093/ibd/izz085.
9
State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.
World J Gastroenterol. 2008 May 7;14(17):2625-9. doi: 10.3748/wjg.14.2625.
10
[Research in inflammatory bowel disease - an obsolescent model or new perspectives?].
Z Gastroenterol. 2012 Apr;50(4):363. doi: 10.1055/s-0031-1299364. Epub 2012 Apr 1.
引用本文的文献
1
New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease.
Dig Dis Sci. 2022 Jan;67(1):42-55. doi: 10.1007/s10620-021-06837-2. Epub 2021 Feb 1.
2
From clinical practice guideline development to trial registration: A systematic investigation of research pipeline for inflammatory bowel disease.
Indian J Gastroenterol. 2019 Jun;38(3):247-262. doi: 10.1007/s12664-019-00965-4. Epub 2019 Jul 3.
3
Crohn's Disease: Potential Drugs for Modulation of Autophagy.
Medicina (Kaunas). 2019 May 29;55(6):224. doi: 10.3390/medicina55060224.
4
Cohort profile of the PRoteomic Evaluation and Discovery in an IBD Cohort of Tri-service Subjects (PREDICTS) study: Rationale, organization, design, and baseline characteristics.
Contemp Clin Trials Commun. 2019 Mar 26;14:100345. doi: 10.1016/j.conctc.2019.100345. eCollection 2019 Jun.
5
Pediatric Inflammatory Bowel Disease Clinical Innovations Meeting of the Crohn's & Colitis Foundation: Charting the Future of Pediatric IBD.
Inflamm Bowel Dis. 2019 Jan 1;25(1):27-32. doi: 10.1093/ibd/izy205.
6
Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.
World J Microbiol Biotechnol. 2018 May 23;34(6):76. doi: 10.1007/s11274-018-2449-0.
7
Establishment and Development of the First Biobank of Inflammatory Bowel Disease, Suspected to Primary Immunodeficiency Diseases in Iran.
Adv Biomed Res. 2018 Mar 27;7:45. doi: 10.4103/abr.abr_278_16. eCollection 2018.
8
Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice.
Dis Model Mech. 2018 Feb 7;11(2):dmm031070. doi: 10.1242/dmm.031070.
9
Inflammatory Bowel Disease Drugs: A Focus on Autophagy.
J Crohns Colitis. 2017 Jan;11(1):118-127. doi: 10.1093/ecco-jcc/jjw127. Epub 2016 Jul 5.
10
Collecting Biospecimens From an Internet-Based Prospective Cohort Study of Inflammatory Bowel Disease (CCFA Partners): A Feasibility Study.
JMIR Res Protoc. 2016 Jan 5;5(1):e3. doi: 10.2196/resprot.5171.
本文引用的文献
1
Risk of natalizumab-associated progressive multifocal leukoencephalopathy.
N Engl J Med. 2012 May 17;366(20):1870-80. doi: 10.1056/NEJMoa1107829.
2
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
Gastroenterology. 2012 Aug;143(2):390-399.e1. doi: 10.1053/j.gastro.2012.05.004. Epub 2012 May 11.
3
The development of LTi cells.
Curr Opin Immunol. 2012 Apr;24(2):178-83. doi: 10.1016/j.coi.2012.02.003. Epub 2012 Mar 1.
4
Are Th17 cells in the gut pathogenic or protective?
Mucosal Immunol. 2012 Jan;5(1):4-6. doi: 10.1038/mi.2011.51. Epub 2011 Nov 9.
5
HNF4α and CDH1 are associated with ulcerative colitis in a Dutch cohort.
Inflamm Bowel Dis. 2011 Aug;17(8):1714-8. doi: 10.1002/ibd.21541. Epub 2010 Nov 28.
6
Increased risk for nonmelanoma skin cancers in patients who receive thiopurines for inflammatory bowel disease.
Gastroenterology. 2011 Nov;141(5):1621-28.e1-5. doi: 10.1053/j.gastro.2011.06.050. Epub 2011 Jun 25.
7
Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification.
Inflamm Bowel Dis. 2011 Jun;17(6):1314-21. doi: 10.1002/ibd.21493. Epub 2010 Nov 8.
8
The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.
Science. 2011 May 20;332(6032):974-7. doi: 10.1126/science.1206095. Epub 2011 Apr 21.
9
Charting a course for genomic medicine from base pairs to bedside.
Nature. 2011 Feb 10;470(7333):204-13. doi: 10.1038/nature09764.
10
Induction of colonic regulatory T cells by indigenous Clostridium species.
Science. 2011 Jan 21;331(6015):337-41. doi: 10.1126/science.1198469. Epub 2010 Dec 23.
Zotero 插件